| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA658134 | F | In vitro growth inhibition against CNS cancer SNB-19 cell line was reported. | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 2. | ALA658135 | F | Log of molar concentration leading to 50% cell death against CNS cancer SNB-19 cell line was reported | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 3. | ALA658136 | F | In vitro total growth inhibition against CNS cancer SNB-19 cell lines was reported. | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 4. | ALA658144 | F | Compound was evaluated in vitro against NCI CNS cancer cell line SNB19 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 5. | ALA876947 | F | Compound was evaluated in vitro against NCI CNS cancer cell line SNB19 at concentration up to 10e -4 mol/L; Not active | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
| 6. | ALA658145 | F | Compound was evaluated in vitro against NCI CNS cancer cell line SNB19; Not active | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 7. | ALA802373 | F | Cytotoxicity against NCI tumor panel, SNB-19 CNS cancer cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 8. | ALA802374 | F | Concentration of compound required to inhibit the growth of SNB-19 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 9. | ALA802375 | F | Effective dose to show cytotoxicity against CNS cancer SNB-19 cell line was determined | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 10. | ALA802376 | F | In vitro cytotoxic activity against central nervous system (CNS) SNB-19 cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 11. | ALA802377 | F | inhibition of the growth of CNS cancer(SNB-19) cell line | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
| 12. | ALA802378 | F | Inhibition of the growth of CNS cancer(SNB-19) cell line at 0.01 uM | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 13. | ALA802379 | F | Inhibition of the growth of CNS cancer(SNB-19) cell line at 0.01 uM | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA802380 | F | Concentration for 50% cell kill against CNS cancer SNB-19 cell line was determined | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA802381 | F | In vitro cytotoxicity against CNS SNB-19 cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA802382 | F | Tested for cytotoxic activity against CNS cancer SNB-19 cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 17. | ALA802383 | F | Compound was tested for growth inhibitory activity against SNB-19 cell line | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 18. | ALA802384 | F | Compound tested for growth inhibition of CNS cancer cell line SNB-19 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 19. | ALA858142 | F | Compound was evaluated for cytostatic activity against SNB-19 CNS cancer cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 20. | ALA802385 | F | Compound was tested for 50% growth inhibition against human CNS cancer SNB-19 cell line | Homo sapiens | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!